A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion.
The main limitations of hematopoietic cord blood (CB) transplantation, viz. low cell dosage and delayed reconstitution, can be overcome by ex-vivo expansion. CB expansion under conventional culture causes the rapid cell differentiation and depletion of hematopoietic stem/progenitor cells (HSPC) resp...
Autori principali: | Tarunina, M, Hernandez, D, Kronsteiner-Dobramysl, B, Pratt, P, Watson, T, Hua, P, Gullo, F, Van der Garde, M, Zhang, Y, Hook, L, Choo, Y, Watt, S |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
Mary Ann Liebert, Inc
2016
|
Documenti analoghi
Documenti analoghi
-
Single-cell assessment of transcriptome alterations induced by Scriptaid in early differentiated human haematopoietic progenitors during ex vivo expansion
di: Hua, P, et al.
Pubblicazione: (2019) -
Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
di: Watt, S, et al.
Pubblicazione: (2007) -
Tailored Cytokine Optimization for ex vivo Culture Platforms Targeting the Expansion of Human Hematopoietic Stem/Progenitor Cells
di: André Branco, et al.
Pubblicazione: (2020-09-01) -
Increasing complexity of molecular landscapes in human hematopoietic stem and progenitor cells during development and aging
di: Watt, SM, et al.
Pubblicazione: (2022) -
An improved medium formulation for efficient ex vivo gene editing, expansion and engraftment of hematopoietic stem and progenitor cells
di: Rajeev Rai, et al.
Pubblicazione: (2023-06-01)